1887

Abstract

Carbapenem-resistant (CR-AB) represents a major health-care problem, causing high rates of morbidity and mortality. This study investigated the clonality of CR-AB isolated from diabetic patients from different regions in Saudi Arabia, as well as the relatedness of the β-lactamase genes. A total of 64 non-repetitive CR-AB clinical isolates were collected from 16 different regions in Saudi Arabia from intensive care patients. Isolates were identified phenotypically by the Vitek 2 compact system and genotypically by amplification of the gene. The target sequences were amplified by PCR and the clonal diversity of the isolates was explored by PFGE. Resistance studies revealed that the prevalence of imipenem and meropenem resistance was 92 % and 96 %, respectively, while the vast majority of the isolates were susceptible to tigecycline and colistin. In addition, and were the most prevalent genes in the isolates under investigation, while IS was the most dominant insertion sequence. PFGE results showed 13 clusters; clone H was dominant, comprising 20 isolates from four hospitals, followed by clones C and F, comprising 11 isolates each from three and six hospitals, respectively. Moreover, the current study signified the clonal diversity of CR-AB in Saudi Arabia and showed the ability of some clones to infect patients in many different cities.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.079640-0
2014-11-01
2019-11-21
Loading full text...

Full text loading...

/deliver/fulltext/jmm/63/11/1460.html?itemId=/content/journal/jmm/10.1099/jmm.0.079640-0&mimeType=html&fmt=ahah

References

  1. Abdalhamid B., Hassan H., Itbaileh A., Shorman M.. ( 2014;). Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia. . New Microbiol 37:, 65–73.[PubMed]
    [Google Scholar]
  2. Agodi A., Voulgari E., Barchitta M., Quattrocchi A., Bellocchi P., Poulou A., Santangelo C., Castiglione G., Giaquinta L.. & other authors ( 2014;). Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. . J Hosp Infect 86:, 260–266. [CrossRef][PubMed]
    [Google Scholar]
  3. Al-Agamy M. H., Khalaf N. G., Tawfick M. M., Shibl A. M., El Kholy A.. ( 2014;). Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. . Int J Infect Dis 22:, 49–54. [CrossRef][PubMed]
    [Google Scholar]
  4. Al-Sweih N. A., Al-Hubail M., Rotimi V. O.. ( 2012;). Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait. . J Infect Public Health 5:, 102–108. [CrossRef][PubMed]
    [Google Scholar]
  5. Alsultan A. A., Evans B. A., Elsayed E. A., Al-Thawadi S. I., Al-Taher A. Y., Amyes S. G. B., Al-Dughaym A. M., Hamouda A.. ( 2013;). High frequency of carbapenem-resistant Acinetobacter baumannii in patients with diabetes mellitus in Saudi Arabia. . J Med Microbiol 62:, 885–888. [CrossRef][PubMed]
    [Google Scholar]
  6. Aly M., Tayeb H. T., Al Johani S. M., Alyamani E. J., Aldughaishem F., Alabdulkarim I., Balkhy H. H.. ( 2014;). Genetic diversity of OXA-51-like genes among multidrug-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia. . Eur J Clin Microbiol Infect Dis 33:, 1223–1228. [CrossRef][PubMed]
    [Google Scholar]
  7. Ambler R. P.. ( 1980;). The structure of β-lactamases. . Philos Trans R Soc Lond B Biol Sci 289:, 321–331. [CrossRef][PubMed]
    [Google Scholar]
  8. Baadani A. M., Thawadi S. I., El-Khizzi N. A., Omrani A. S.. ( 2013;). Prevalence of colistin and tigecycline resistance in Acinetobacter baumannii clinical isolates from 2 hospitals in Riyadh Region over a 2-year period. . Saudi Med J 34:, 248–253.[PubMed]
    [Google Scholar]
  9. Bahador A., Taheri M., Pourakbari B., Hashemizadeh Z., Rostami H., Mansoori N., Raoofian R.. ( 2013;). Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. . Microb Drug Resist 19:, 397–406. [CrossRef][PubMed]
    [Google Scholar]
  10. Bassetti M., Ginocchio F., Mikulska M., Taramasso L., Giacobbe D. R.. ( 2011;). Will new antimicrobials overcome resistance among Gram-negatives. ? Expert Rev Anti Infect Ther 9:, 909–922. [CrossRef][PubMed]
    [Google Scholar]
  11. Brown S., Amyes S.. ( 2006;). OXA (β)-lactamases in Acinetobacter: the story so far. . J Antimicrob Chemother 57:, 1–3. [CrossRef][PubMed]
    [Google Scholar]
  12. CLSI ( 2012;). Performance Standards for Antimicrobial Susceptibility Testing. Approved Standard, 22nd Informational Supplement M100-S22. . Wayne, PA:: Clinical and Laboratory Standards Institute;.
  13. Coelho J. M., Turton J. F., Kaufmann M. E., Glover J., Woodford N., Warner M., Palepou M. F., Pike R., Pitt T. L.. & other authors ( 2006;). Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. . J Clin Microbiol 44:, 3623–3627. [CrossRef][PubMed]
    [Google Scholar]
  14. Corvec S., Caroff N., Espaze E., Giraudeau C., Drugeon H., Reynaud A.. ( 2003;). AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. . J Antimicrob Chemother 52:, 629–635. [CrossRef][PubMed]
    [Google Scholar]
  15. Dijkshoorn L., Aucken H., Gerner-Smidt P., Janssen P., Kaufmann M. E., Garaizar J., Ursing J., Pitt T. L.. ( 1996;). Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. . J Clin Microbiol 34:, 1519–1525.[PubMed]
    [Google Scholar]
  16. Ellington M. J., Kistler J., Livermore D. M., Woodford N.. ( 2007;). Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. . J Antimicrob Chemother 59:, 321–322. [CrossRef][PubMed]
    [Google Scholar]
  17. Héritier C., Poirel L., Nordmann P.. ( 2006;). Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. . Clin Microbiol Infect 12:, 123–130. [CrossRef][PubMed]
    [Google Scholar]
  18. Karunasagar A., Maiti B., Shekar M., Shenoy M S., Karunasagar I.. ( 2011;). Prevalence of OXA-type carbapenemase genes and genetic heterogeneity in clinical isolates of Acinetobacter spp. from Mangalore, India. . Microbiol Immunol 55:, 239–246. [CrossRef][PubMed]
    [Google Scholar]
  19. Lambiase A., Piazza O., Rossano F., Del Pezzo M., Tufano R., Catania M. R.. ( 2012;). Persistence of carbapenem-resistant Acinetobacter baumannii strains in an Italian intensive care unit during a forty-six month study period. . New Microbiol 35:, 199–206.[PubMed]
    [Google Scholar]
  20. Lee K., Yong D., Jeong S. H., Chong Y.. ( 2011;). Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. . Yonsei Med J 52:, 879–891. [CrossRef][PubMed]
    [Google Scholar]
  21. Lu P. L., Doumith M., Livermore D. M., Chen T. P., Woodford N.. ( 2009;). Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. . J Antimicrob Chemother 63:, 641–647. [CrossRef][PubMed]
    [Google Scholar]
  22. Manikal V. M., Landman D., Saurina G., Oydna E., Lal H., Quale J.. ( 2000;). Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. . Clin Infect Dis 31:, 101–106. [CrossRef][PubMed]
    [Google Scholar]
  23. Maragakis L. L., Perl T. M.. ( 2008;). Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. . Clin Infect Dis 46:, 1254–1263. [CrossRef][PubMed]
    [Google Scholar]
  24. Miranda G., Kelly C., Solorzano F., Leanos B., Coria R., Patterson J. E.. ( 1996;). Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonatal intensive care unit. . J Clin Microbiol 34:, 3138–3141.[PubMed]
    [Google Scholar]
  25. Mohajeri P., Farahani A., Feizabadi M. M., Ketabi H., Abiri R., Najafi F.. ( 2013;). Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran. . Iran J Microbiol 5:, 195–202.[PubMed]
    [Google Scholar]
  26. Oteo J., García-Estébanez C., Migueláñez S., Campos J., Martí S., Vila J., Domínguez M. A., Docobo F., Larrosa N.. & other authors ( 2007;). Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain. . J Infect 55:, 260–266. [CrossRef][PubMed]
    [Google Scholar]
  27. Papp-Wallace K. M., Endimiani A., Taracila M. A., Bonomo R. A.. ( 2011;). Carbapenems: past, present, and future. . Antimicrob Agents Chemother 55:, 4943–4960. [CrossRef][PubMed]
    [Google Scholar]
  28. Paton R., Miles R. S., Hood J., Amyes S. G. B., Miles R. S., Amyes S. G.. ( 1993;). ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. . Int J Antimicrob Agents 2:, 81–87. [CrossRef][PubMed]
    [Google Scholar]
  29. Peleg A. Y., Seifert H., Paterson D. L.. ( 2008;). Acinetobacter baumannii: emergence of a successful pathogen. . Clin Microbiol Rev 21:, 538–582. [CrossRef][PubMed]
    [Google Scholar]
  30. Poirel L., Nordmann P.. ( 2006a;). Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. . Clin Microbiol Infect 12:, 826–836. [CrossRef][PubMed]
    [Google Scholar]
  31. Poirel L., Nordmann P.. ( 2006b;). Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. . Antimicrob Agents Chemother 50:, 1442–1448. [CrossRef][PubMed]
    [Google Scholar]
  32. Poirel L., Potron A., Nordmann P.. ( 2012;). OXA-48-like carbapenemases: the phantom menace. . J Antimicrob Chemother 67:, 1597–1606. [CrossRef][PubMed]
    [Google Scholar]
  33. Qi C., Malczynski M., Parker M., Scheetz M. H.. ( 2008;). Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. . J Clin Microbiol 46:, 1106–1109. [CrossRef][PubMed]
    [Google Scholar]
  34. Shahcheraghi F., Abbasalipour M., Feizabadi M., Ebrahimipour G., Akbari N.. ( 2011;). Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. . Iran J Microbiol 3:, 68–74.[PubMed]
    [Google Scholar]
  35. Souli M., Galani I., Giamarellou H.. ( 2008;). Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. . Euro Surveill 13:, 19045.http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19045[PubMed]
    [Google Scholar]
  36. Turton J. F., Ward M. E., Woodford N., Kaufmann M. E., Pike R., Livermore D. M., Pitt T. L.. ( 2006a;). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. . FEMS Microbiol Lett 258:, 72–77. [CrossRef][PubMed]
    [Google Scholar]
  37. Turton J. F., Woodford N., Glover J., Yarde S., Kaufmann M. E., Pitt T. L.. ( 2006b;). Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. . J Clin Microbiol 44:, 2974–2976. [CrossRef][PubMed]
    [Google Scholar]
  38. Villalón P., Valdezate S., Medina-Pascual M. J., Carrasco G., Vindel A., Saez-Nieto J. A.. ( 2013;). Epidemiology of the Acinetobacter-derived cephalosporinase, carbapenem-hydrolysing oxacillinase and metallo-β-lactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii from Spain. . J Antimicrob Chemother 68:, 550–553. [CrossRef][PubMed]
    [Google Scholar]
  39. Walther-Rasmussen J., Høiby N.. ( 2006;). OXA-type carbapenemases. . J Antimicrob Chemother 57:, 373–383. [CrossRef][PubMed]
    [Google Scholar]
  40. Wang X., Qiao F., Yu R., Gao Y., Zong Z.. ( 2013;). Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study. . BMC Microbiol 13:, 234. [CrossRef][PubMed]
    [Google Scholar]
  41. Woodford N., Ellington M. J., Coelho J. M., Turton J. F., Ward M. E., Brown S., Amyes S. G., Livermore D. M.. ( 2006;). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.. Int J Antimicrob Agents 27:, 351–353. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.079640-0
Loading
/content/journal/jmm/10.1099/jmm.0.079640-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error